Chemokine and chemokine receptors: A comparative study between metastatic and nonmetastatic lymph nodes in breast cancer patients

European Cytokine Network

Volumn 23, Issue 3, 2012, Pages 72-77

  Razmkhah, Mahboobeh ^a   Jaberipour, Mansoureh ^a   Safaei, Akbar ^b   Talei, Abdol Rasoul ^b   Erfani, Nasrollah ^a   Ghaderi, Abbass ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Chemokine; Chemokine receptor; Lymph node; Metastasis

Indexed keywords

CD3 ANTIGEN; CD69 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; COMPLEMENTARY DNA; CXCL13 CHEMOKINE; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CELL ISOLATION; CLINICAL ARTICLE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; LYMPH NODE METASTASIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

AGING; BREAST NEOPLASMS; CHEMOKINES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; RECEPTORS, CHEMOKINE; RNA, MESSENGER;

EID: 84868097746     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2012.0310     Document Type: Article

References (21)

1. Raman D, Baugher PJ, Thu YM, Richmond A. Role of chemokines in tumor growth. Cancer Lett 2007; 256: 137-65.
2. Wang J, Xi L, Gooding W, Godfrey TE, Ferris RL. Chemokine receptors 6 and 7 identify a metastatic expression pattern in squamous cell carcinoma of the head and neck. Adv Otorhinolaryngol 2005; 62: 121-33.
3. Ishigami S, Natsugoe S, Nakajo A, et al. Prognostic value of CCR7 expression in gastric cancer. Hepatogastroenterology 2007; 54: 1025-8.
4. Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-6.
5. Oliveira-Neto HH, Silva ET, Leles CR, et al. Involvement of CXCL12 and CXCR4 in lymph node metastases and development of oral squamous cell carcinomas. Tumour Biol 2008; 29: 262-71.
6. Morales J, Homey B, Vicari AP, et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999; 96: 14470-5.
7. Monteagudo C, Martin JM, Jorda E, Llombart-Bosch A. CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathologic prognostic factors. J Clin Pathol 2007; 60: 596-9.
8. Kawada K, Sonoshita M, Sakashita H. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res 2004; 64: 4010-7.
9. Soria G, Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 2008; 267: 271-85.
10. Battaglia A, Buzzonetti A, Baranello C, et al. Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer. Cancer Immunol Immunother 2009; 58: 1363-73.
11. Ishida T, Ueda R. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci 2006; 97: 1139-46.
12. Cabioglu N, Yazici MS, Arun B, et al. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res 2005; 11: 5686-93.
13. Kang H, Watkins G, Douglas-Jones A, Mansel RE, Jiang WG. The elevated level ofCXCR4is correlated with nodal metastasis of human breast cancer. Breast 2005; 14: 360-7.
14. Yasuoka H, Tsujimoto M, Yoshidome K, et al. Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis. BMC Cancer 2008; 8: 340.
15. Tanaka K, Kurebayashi J, Sohda M, et al. The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence. Thyroid 2009; 19: 21-5.
16. Ferreira FO, Ribeiro FL, Batista AC, et al. Association of CCL2 with lymph node metastasis and macrophage infiltration in oral cavity and lip squamous cell carcinoma. Tumour Biol 2008; 29: 114-21.
17. Soria G,Yaal-Hahoshen N, Azenshtein E, et al. Concomitant expression of the chemokinesRANTESand MCP-1 in human breast cancer: A basis for tumor-promoting interactions. Cytokine 2008; 44: 191-200.
18. Cambiaggi C, Scupoli MT, Cestari T, et al. Constitutive expression ofCD69in interspeciesT-cell hybrids and locus assignment to human chromosome 12. Immunogenetics 1992; 36: 117-20.
19. Yacyshyn MB, Poppema S, Berg A, et al. CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy. Int J Cancer 1995; 61: 470-4.
20. Wysocki CA, Jiang Q, Panoskaltsis-Mortari A, et al. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood 2005; 106: 3300-7.
21. Panse J, Friedrichs K, Marx A, et al. Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients. Brit J Cancer 2008; 99: 930-8.